LOVD - Variant listings for BRCA2

Patient data (#0001940)
Disease -
Reference United States:Salt Lake City
Template DNA
Technique SEQ
Remarks -
# Reported 1
Submitter Tiana Francy

Variant data
Allele Unknown
Reported pathogenicity -
Concluded pathogenicity No known pathogenicity
Exon 19
DNA change c.8351G>A
BIC DNA change 8579G>A
Protein change p.R2784Q
Posterior P 1.69404E-05
IARC Class 1 - Not pathogenic or of no clinical significance
Key Observational Reference Parsons et al 2019
Prior P reference -
Missense analysis Prior P 0.66
Splicing prior P -
Other Prior P 0.02
Combined prior P 0.66
Segregation LR 0.000106872
Pathology LR 1.134894587
Sum Family LR 1.480815593
Co-occurrence LR 0.048590003
case-control LR -
Product of LRs 0.00000872701
Comments Two functional assays report that this variant has a complete functional impact (Mesman et al 2018, Hart et al 2018).

1 entry in BRCA2

Path. Allele
Exon Descending
Ascending
DNA change Descending
Ascending
BIC DNA change Descending
Ascending
Protein change Descending
Ascending
Posterior P Descending
Ascending
IARC Class Descending
Ascending
Key Observational Reference Descending
Ascending
Prior P reference Descending
Ascending
Missense analysis Prior P Descending
Ascending
Splicing prior P Descending
Ascending
Other Prior P Descending
Ascending
Combined prior P Descending
Ascending
Segregation LR Descending
Ascending
Pathology LR Descending
Ascending
Sum Family LR Descending
Ascending
Co-occurrence LR Descending
Ascending
case-control LR Descending
Ascending
Product of LRs Descending
Ascending
Comments Descending
Ascending
- Unknown 19 c.8351G>A 8579G>A p.R2784Q 1.69404E-05 1 - Not pathogenic or of no clinical significance Parsons et al 2019 - 0.66 - 0.02 0.66 0.000106872 1.134894587 1.480815593 0.048590003 - 0.00000872701 Two functional assays report that this variant has a complete functional impact (Mesman et al 2018, Hart et al 2018).